Evidence has shown convincingly that sphingolipids, ceramide in particular, contribute to key steps in NAFLD onset, including the disruption of insulin sensitivity and mitochondrial metabolism, the metabolic derangement, and the stimulation of cell death 24, 25. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.